Skip to content
Catalyst

rosuvastatinFinding

Rosuvastatin decreases diastolic blood pressure (setting unspecified)

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“The patients treated with rosuvastatin in addition to antihypertensives had a significantly lower DBP (MD = −2.12 mmHg; 95% CI = −3.72 to −0.52; Pfixed-effects model = 0.009; I 2 = 0%, Pheterogeneity = 0.97) than the patients treated with antihypertensives alone.”
Quoted verbatim from Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.
This finding among the 85 findings on its endpoint

rosuvastatin

Diastolic blood pressure (setting unspecified)

lowers

Effect as reported

−2.12mean difference

CI −3.72 to −0.52

Who
Patients with hypertension and dyslipidemia treated with rosuvastatin 20 mg/day plus antihypertensive agents (an ARB, or an ARB plus a calcium channel blocker), compared with the same antihypertensive background alone
Dose studied
rosuvastatin 20 mg/day

Moderate evidencePMID 34818350 · 2021

02 · The study

Study
meta-analysis
Duration
8 weeks

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PEXHTDEXZED69J2D5V19X7